Protein found that drives ageing without inflammation
Archived — this story has rotated out of today’s deck. It is kept here in full.
The gist
Monash researchers found Granzyme K drives age-related organ damage in mice independently of immune ageing.
The work is mouse-based, so whether blocking it helps people is still untested.
Background
Nicole La Gruta, a professor and senior researcher at the Monash Biomedicine Discovery Institute at Monash University in Melbourne, led the team. Granzyme K is a protein made by immune cells whose levels rise substantially with age in both mice and humans, but its role in organ damage was unclear. The study, published in the journal Immunity, compared aged normal mice with mice engineered to lack the protein, and the findings challenge the assumption that organ and immune ageing are inextricably linked.
How it unfolded
- Nov 12, 2026Research published in the journal Immunity identifies Granzyme K as a driver of age-related tissue remodelling and functional decline, independent of age-associated immune dysfunction.
- Nov 12, 2026Mice lacking Granzyme K showed significantly improved heart function, reduced fibrosis and fewer signs of age-related damage in liver and kidneys.
- Nov 12, 2026Analysis of human datasets found elevated Granzyme K in patients with inflammatory and fibrotic diseases, including lupus nephritis and heart failure.
- Nov 13, 2026Coverage reports the project ran about four years, with mice raised 18 months to two years until biologically equivalent to a 70-year-old adult; blood tests showed far less liver damage in mice without the protein.
Key terms
- fibrosis
- The formation of fibrous connective tissue, often excessive, in an organ or tissue in response to injury or disease.
- lupus nephritis
- Inflammation of the kidneys caused by systemic lupus erythematosus, an autoimmune disease.
Source: Wikipedia
Who’s saying what
- Expert
- La Gruta says mice without the protein showed reduced organ ageing even though their immune systems aged normally, challenging the view that organ and immune ageing are inextricably linked.
- Caution
- La Gruta says further work is needed on whether blocking the protein later in life, or achieving the same benefits in humans, is possible.
Still unverified
Whether blocking Granzyme K later in life could match the benefits of lifelong absence of the protein is not established; whether the same benefits apply in humans is also unestablished, since the human data came from existing retrospective datasets and clinical trials would be needed.